Does XERF Cause Fat Loss?

As XERF has grown in popularity, one question comes up again and again: does it melt facial fat, or is it purely a skin tightening treatment?

This matters, because if you have a concern that is actually about fat rather than skin laxity, XERF is the wrong tool for the job, no matter how good the tightening results are.

The current evidence indicates that XERF is designed to remodel collagen, not destroy fat cells. Here is what the research actually shows, why the distinction matters, and what to do if fat reduction, not tightening, is your actual goal.

Confusion here is understandable. Some energy-based devices genuinely do target fat. Laser lipolysis and certain radiofrequency body contouring devices are specifically engineered to heat fat cells to the point of cell death.

Other treatments, like XERF, are engineered specifically to avoid that threshold and act on collagen instead. Both use heat. The difference is entirely in the temperature reached and the tissue targeted, which is a distinction easy to miss if you are only reading marketing copy rather than the underlying mechanism.

Skin and fat respond very differently depending on how hot they get. This is the entire basis for how XERF is designed to work.

Collagen remodelling begins at around 40 to 48°C, with the most effective, sustained new collagen production (called neocollagenesis) triggered at approximately 43°C, held for several minutes. This is the range associated with tightening, firming, and improved skin quality, without damaging the tissue.

Fat cell destruction requires meaningfully higher temperatures, generally in the range of 60 to 70°C, sustained long enough to compromise the structural integrity of the fat cell membrane. This is the mechanism used deliberately in treatments designed specifically for fat reduction.

XERF is engineered to stay within the lower, collagen-remodelling range. Its integrated cooling system maintains the skin’s surface temperature between roughly 38 and 42°C throughout treatment, while allowing therapeutic heating to reach the deeper dermal layers and the SMAS fascia, without crossing into the temperature range associated with fat cell damage.

Two recent studies are directly relevant here, and both point in the same direction.

A 2025 study published in Lasers in Medical Science (Ko et al.) specifically tested for adipocyte apoptosis, meaning fat cell death, in tissue treated with dual-frequency radiofrequency at XERF’s operating frequencies. Using a TUNEL assay, a recognised method for detecting cell death, researchers found no adipocyte apoptosis at any point up to 30 days after treatment. In plain terms, the fat cells examined remained structurally intact.

Read the full study here →

A separate study published in Skin Research and Technology in 2024 (Hong et al.) examined tissue six hours after treatment with the same dual-frequency approach and found clear histological evidence of collagen bundle thickening and contraction, alongside thickening of the fascial layers, consistent with the tightening effect patients report feeling during and after treatment.

Read the full study here →

Together, these findings support the same conclusion: XERF appears to work by remodelling collagen and connective tissue, not by destroying fat. It is worth noting, in the interest of full transparency, that both studies were conducted on animal tissue rather than in large human clinical trials, which is typical for a newer technology and something a responsible practitioner should be upfront about rather than glossing over.

This is not a limitation of the technology, it is the intended design. XERF selectively engages the fibro-septal network, the connective tissue structure that runs from the dermis down into the SMAS fascia, while working to avoid unwanted disruption to the fat layer in between. This dual-layer, fat-conscious approach is precisely what allows XERF to tighten and lift without the volume loss or hollowing that can sometimes occur with treatments that are more aggressive toward fat.

For patients specifically concerned about preserving facial volume while still addressing skin laxity, this is one of XERF’s genuine clinical advantages, and part of what has driven its rapid adoption among dermatologists assessing it on the evidence rather than the hype.

If what you are really looking for is a reduction in facial or body fat, whether that is a fuller lower face, submental fullness under the chin, or stubborn fat elsewhere on the body, XERF is not the right primary treatment, regardless of how good its tightening results are. This is a genuinely important distinction to get right before booking anything.

For facial and body fat reduction, two treatments are specifically designed for the job:

• Fat dissolving injections, using deoxycholic acid to break down and permanently eliminate localised fat deposits such as a double chin, over a course of sessions
• Laser liposuction, a minimally invasive treatment that directly targets and removes fat from larger areas with more significant volume

Many patients in fact benefit from a combined approach: fat reduction to address volume first, followed by XERF to tighten the skin once the fat has been addressed. This sequencing question, and whether it applies to you, is exactly the kind of thing worth discussing properly at consultation rather than guessing at from home.

To be clear about what XERF is genuinely excellent at: skin laxity, early jowling, loss of jawline definition, and general skin quality decline, all driven by collagen and connective tissue changes rather than excess fat.

If this describes your concern, XERF remains one of the most credible non-surgical options available. Our guide on whether you are a good candidate for XERF covers this distinction in more depth, and our article on XERF results and how long they last explains what that tightening looks like over time.

No. The current evidence does not support the idea that XERF causes meaningful fat loss, and it is not designed to.

It operates within a thermal range specifically intended to remodel collagen, roughly 40 to 48°C, well below the 60 to 70°C threshold understood to damage fat cells. Published research to date, including histological and cell-death studies, is consistent with this: collagen and connective tissue respond and remodel, while fat cells remain structurally intact.

If skin laxity, loss of firmness, or softened jawline definition is your concern, this is exactly the mechanism you want, and XERF remains one of the most credible non-surgical options available. If fat reduction is your actual goal, XERF is the wrong starting point, and fat dissolving or laser liposuction will serve you far better.

A properly qualified consultation should always clarify which concern you actually have before recommending any treatment. The two are easy to conflate but require entirely different approaches.